alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 23.1**

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by referencein the Registration Statement of Innovus Pharmaceuticals, Inc. (the “Company”) on Form S-8 (No. 333-186725-13620840),pertaining to the Company’s Incentive Stock Option Plan, Nonstatutory Stock Option Agreement, and the Company’s EquityIncentive Plan, of our report dated March 19, 2013, on our audits of the consolidated financial statements as of December 31, 2012and 2011 and for the period from inception (October 31, 2008) to December 31, 2012, which report is included in the Annual Reporton Form 10-K filed on March 19, 2013. Our report includes an emphasis-of-matter paragraph highlighting the funding commitment fromthe President and Chief Executive Office of the Company.

 

/s/Eisner Amper LLP

 

Edison, New Jersey

 

March 19, 2013
EXHIBIT 32.1

CERTIFICATION  OF  PRINCIPAL  EXECUTIVE  OFFICER  AND  PRINCIPAL
FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002.+


      In connection  with the  accompanying  Annual Report on Form 10-KSB of Pro
Squared,  Inc.  for the fiscal year ended  December 31,  2003,  the  undersigned
hereby  certifies  pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to
Section 906 of the  Sarbanes-Oxley  Act of 2002, to the best of my knowledge and
belief, that:

(1)   such Annual  Report on Form 10-KSB for the fiscal year ended  December 31,
      2003 fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and

(2)   the  information  contained  in such Annual  Report on Form 10-KSB for the
      fiscal  year ended  December  31, 2003 fairly  presents,  in all  material
      respects, the financial condition and results of operations.


April 14, 2004                    /s/ Craig Crawford
                                  -----------------------------------------
                                  Name:  Craig Crawford
                                  Title: Chief Executive Officer and Chief
                                         Financial Officer
Jeremy BARNES, petitioner, v. UNITED STATES.

No. 12-7769.

Supreme Court of the United States

June 24, 2013.

On petition for writ of certiorari to the United States Court of Appeals for the First Circuit. Motion of petitioner for leave to proceed *in forma pauperis* and petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the First Circuit for further consideration in light of *Alleyne v. United States,* --- U.S. ----, 133 S.Ct. 2151, --- L.Ed. ---- (2013).
UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF INDIANA

HAMMOND DIVISION

RYAN BABJAK and DENISE BABJAK, )

Plaintiffs, )

)

v. ) Cause No.: 2:15-CV-40-JVB-PRC

)

ARCELORMITTAL USA, LLC and )

ARCELORMITTAL INDIANA HARBOR, )

LLC, )

Defendants. )

OPINION AND ORDER

This matter comes before the Court pursuant to this Court’s August 9, 2016 Opinion and

Order on Plaintiffs’ Motion to Compel. The Court granted that motion, ordering Defendants to

submit to depositions under Federal Rule of Civil Procedure 30(b)(6). The motion did not ask for

attorney fees. However, Federal Rule of Civil Procedure 37 states that fees and costs must be

awarded to the prevailing party. Fed. R. Civ. P. 37(a)(5). There are a few exceptions to this rule, and

the Court may only award fees after the losing side has had an opportunity to be heard on the issue.

Id. The Court accordingly set deadlines for briefing on whether attorney fees should be awarded.

Defendant has not filed an objection to the award of reasonable expenses, and the time to do so has

passed.

Federal Rule of Civil Procedure 37 provides that if a Motion to Compel is granted—“or if

the disclosure or requested discovery is provided after the motion was filed—the court must, after

giving opportunity to be heard, require the party . . . whose conduct necessitated the motion, the

party or attorney advising that conduct, or both to pay the movant’s reasonable expenses incurred

in making the motion, including attorney’s fees.” Fed. R. Civ. P. 37(a)(5)(A). The Rule provides

three exceptions: (i) if the motion was filed before the movant attempted in good faith to get the
discovery without court action; (ii) if “the opposing party’s non-disclosure, response, or objection

was substantially justified”; or (iii) if “other circumstances make an award of expenses unjust.” Id.

“The burden of persuasion is on the losing party to avoid assessment of expenses and fees, rather

than on the winning party to obtain such an award.” Lincoln Diagnostics, Inc. v. Panatrex, Inc., No.

07-CV-2077, 2008 WL 4330182, at *3 (C.D. Ill. Sept. 16, 2008) (quoting Steadfast Ins. Co. v. Auto

Mktg. Network, Inc., No. 97 C 5696, 1999 WL 446691, at *1 (N.D. Ill. June 23, 1999)).

Because Defendants have not filed an objection, they have not met their burden of showing

that it would be unjust to award reasonable expenses.

The Court AWARDS Plaintiffs reasonable attorney fees and costs incurred in making the

Motion to Compel. The Court ORDERS Plaintiffs’ attorney to file an affidavit detailing the costs

and fees incurred in litigating the motion by September 2, 2016. Defendants may file an objection

(as to the amount of reasonable expenses only) by September 16, 2016, and, if an objection is filed,

Plaintiffs may file a response no later than September 30, 2016.

SO ORDERED this 24th day of August, 2016. 

s/ Paul R. Cherry 

MAGISTRATE JUDGE PAUL R. CHERRY

UNITED STATES DISTRICT COURT

2
# EXHIBIT 32

CERTIFICATION
Pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

We, the undersigned, certify that, to
the best of our knowledge, this quarterly report on Form 10-QSB for the quarter ended
June 30, 2006, of CAPITAL REALTY INVESTORS-II LIMITED PARTNERSHIP, and containing the
financial statements, fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, and that the information contained in this quarterly
report fairly presents, in all material respects, the financial condition and results of
operations of the small business issuer.

|               |  | CAPITAL REALTY INVESTORS-II LIMITED     PARTNERSHIP                                                                                                                          
|-------------- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|               |  | (Small Business Issuer)                                                                                                                                                      
|               |  | by:  C.R.I., Inc.                                                                                                                                                            
|               |  | Managing General Partner                                                                                                                                                     
|August 8, 2006 |  | by:  /s/ William B. Dockser                                                                                                                                                  
|DATE           |  | William B. Dockser,
                  Director, Chairman of the Board,
                  and Treasurer
                  (Principal Executive Officer)                       
|August 8, 2006 |  | by:  /s/ H. William Willoughby                                                                                                                                               
|DATE           |  | H. William Willoughby,
                  Director, President, Secretary,
                    Principal Financial Officer and
                    Principal Accounting Officer

This
certification accompanies this quarterly report and is made solely for purpose of
18 U.S.C. Section 1350, subject to the knowledge standard contained therein, and not
for any other purpose, and shall not be deemed filed by the small business issuer for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
SECTION 302 CERTIFICATIONS

I, Andrew Dale Paul, Principal Executive Officer, Chief Executive Officer,
President and Chairman of Centurion Gold Holdings, Inc., certifies that:

1. I have reviewed this annual report on Form 10-KSB/A of Centurion Gold
Holdings, Inc.;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d- 14) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this annual report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this annual
report (the "Evaluation Date"); and

c) presented in this annual report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. The registrant's other certifying officers and I have indicated in this
annual report whether there were any changes in internal controls or in other
factors that could significantly affect internal controls subsequent to the date
of our most recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.

Date: December 17, 2004


By:             /s/ Andrew Dale Paul
                ---------------------------------------------------
                    Andrew Dale Paul
                    Principal Executive Officer,
                    Chief Executive Officer, President and Chairman
UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF INDIANA

FORT WAYNE DIVISION

UNITED STATES OF AMERICA )

)

v. ) No. 1:15-cr-00025-TLS-SLC

)

CHARLES D. ST. CLAIR )

FINDINGS AND RECOMMENDATION

OF THE MAGISTRATE JUDGE

UPON A PLEA OF GUILTY

TO: THE HONORABLE THERESA L. SPRINGMANN, JUDGE, 

UNITED STATES DISTRICT COURT

Upon Defendant’s request to enter a plea of guilty pursuant to Rule 11 of the Federal

Rules of Criminal Procedure, this matter came on for hearing before U.S. Magistrate Judge

Susan Collins, on May 18, 2016, with the written consents of Defendant, counsel for

Defendant, and counsel for the United States of America.

The hearing on Defendant’s plea of guilty was in full compliance with Rule 11, Federal

Rules of Criminal Procedure, before the Magistrate Judge in open court and on the record.

In consideration of that hearing and the statements made by Defendant under oath on

the record and in the presence of counsel, the remarks of the Assistant United States Attorney

and of counsel for Defendant,

I FIND as follows:

(1) that Defendant understands the nature of the charge against him to which the plea is

offered;

(2) that Defendant understands his right to trial by jury, to persist in his plea of not

guilty, to the assistance of counsel at trial, to confront and cross-examine adverse witnesses,
and his right against compelled self-incrimination;

(3) that Defendant understands what the maximum possible sentence is, including the

effect of the supervised release term, and Defendant understands that the Sentencing Guidelines

apply and that the Court may depart from those guidelines under some circumstances;

(4) that the plea of guilty by Defendant has been knowingly and voluntarily made and is

not the result of force or threats or of promises apart from the plea agreement between the

parties;

(5) that Defendant is competent to plead guilty;

(6) that Defendant understands that his answers may later be used against him in a

prosecution for perjury or false statement;

(7) that there is a factual basis for Defendant’s plea; and further,

I RECOMMEND that the Court accept Defendant’s plea of guilty and that Defendant

be adjudged guilty of the offense charged in the single-count Indictment, and have sentence

imposed. A Presentence Report has been ordered. Should this Findings and Recommendation

be accepted and Defendant adjudged guilty, sentencing will be scheduled before Judge Theresa

L. Springmann by separate order and notice. Objections to the Findings and Recommendation

are waived unless filed and served within fourteen (14) days. 28 U.S.C. § 636(b)(1)(B).

DATED this 18th day of May 2016.

/s/ Susan Collins 

Susan Collins,

United States Magistrate Judge

2
|                                                 | 1997 | 1998  | 1999   | 2000  | 2001   | 2002 | 2003   | 2004   | 2005   | 2006 |
|------------------------------------------------------|------|-------|--------|-------|--------|------|--------|--------|--------|------|
| 1047                                                 | 1027 | 992.6 | 1001.2 | 958.7 | 1132.3 | 1010 | 1085.8 | 1037.7 |   |
| 330.3                                                | 175  | 163.8 | 120    | 85.1  | 57.6   | 25.4 | 26.3   | 21.5   |   |
| Note: All staffing totals reflect year-end balances. |
**EXHIBIT 32.2**

 

***CERTIFICATION PURSUANTTO***

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**

 

Inconnection with the Quarterly Report of ARBOR ENTECH CORPORATION (the “Company”)on Form 10-QSB for the quarter ended October 31, 2005 (the “Form 10-QSB”),I, Mark Shefts, Chief Financial Officer of the Company, certify, as of the datehereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that to the best of my****knowledge,that the Company’s Form 10-QSB fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 and that the informationcontained in the Form 10-QSB, fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 
| Dated December 15,  2005 | /s/Mark Shefts                        |   |
|-------------------------------|---------------------------------------|--------|
|                          | Mark Shefts, Chief  Financial Officer |

 

----
[Federal Register Volume 60, Number 98 (Monday, May 22, 1995)]
[Sunshine Act Meetings]
[Page 27151]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-12610]





                Sunshine Act Meetings



Federal Register / Vol. 60, No. 98 / Monday, May 22, 1995 / Sunshine 
Act Meetings
[[Page 27151]] 




Commodity Futures Trading Commission

TIME AND DATE: 11:00 a.m., Friday, June 2, 1995.

PLACE: 2033 K St., N.W., Washington, D.C. 8th Floor Hearing Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-254-6314.
Jean A. Webb,

Secretary of the Commission.

[FR Doc. 95-12610 Filed 5-18-95; 3:00 pm]

BILLING CODE 6351-01-M
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               DEC-31-2000
<CASH>                                           1,355
<SECURITIES>                                         0
<RECEIVABLES>                                    2,044
<ALLOWANCES>                                         0
<INVENTORY>                                      4,078
<CURRENT-ASSETS>                                 7,807
<PP&E>                                           5,457
<DEPRECIATION>                                   3,328
<TOTAL-ASSETS>                                  11,356
<CURRENT-LIABILITIES>                            1,399
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        13,088
<OTHER-SE>                                     (3,131)
<TOTAL-LIABILITY-AND-EQUITY>                    11,356
<SALES>                                          8,856
<TOTAL-REVENUES>                                     0
<CGS>                                            6,881
<TOTAL-COSTS>                                    4,303
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (2,261)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,261)
<EPS-BASIC>                                      (.23)
<EPS-DILUTED>                                    (.23)


</TABLE>
[Federal Register Volume 60, Number 103 (Tuesday, May 30, 1995)]
[Notices]
[Page 28160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-13049]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Initial Review Group (IRG) meetings:

Name of IRG: Heart, Lung, and Blood Program Project Review Committee
Date: June 22, 1995
Time: 8:00 a.m.
Place: Holiday Inn, Chevy Chase, Maryland
Contact Person: Dr. Jeffrey H. Hurst, 6701 Rockledge Drive, Room 
7208, Bethesda, Maryland 20892-7924,(301) 435-0303
Purpose/Agenda: To review and evaluate grant applications.

Name of IRG: Research Training Review Committee
Date: June 25-27, 1995
Time: 7:30 p.m.
Place: Hyatt Regency, Bethesda, Maryland
Contact Person: Dr. Kathryn Ballard, 6701 Rockledge Drive Room 7194, 
Bethesda, Maryland 20892-7924, (301) 435-0288
Purpose/Agenda: To review and evaluate grant applications.

Name of IRG: Clinical Trials Review Committee
Date: June 25-27, 1995
Time: 7:00 p.m.
Place: Hyatt Regency, Bethesda, Maryland
Contact Person: Dr. David M. Monsees, 6701 Rockledge Drive, Room 
7178, Bethesda, Maryland 20892-7924, (301) 435-0270
Purpose/Agenda: To review and evaluate grant applications.

    These meetings will be closed in accordance with the provisions 
set forth in sec. 552(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: May 18, 1995.
Anna Snouffer,
Committee Management Specialist, NIH.
[FR Doc. 95-13049 Filed 5-26-95; 8:45 am]
BILLING CODE 4140-01-M
AO 450 (Rev. 01/09) Judgment in a Civil Action 

UNITED STATES DISTRICT COURT

for the 

Northern District of Indiana 

DWAINE BARTLETT 

 Petitioner 

 v. 

 Civil Action No. 1:20-cv-175 

 Arising from 1:14-cr-14 

UNITED STATES OF AMERICA 

 Respondent 

JUDGMENT IN A CIVIL ACTION

The court has ordered that (check one): 

 the plaintiff________________________________________________________________________ 

recover from the defendant the amount of_____________ 

dollars $ , which includes prejudgment interest at the rate of % plus postJudgment interest at the rate of % along with costs. 

 the plaintiff recover nothing, the action is dismissed on the merits, and the defendant____________ 

recover costs from the plaintiff . 

 X Other: The Motion to Vacate under 28 U.S.C. 2255 is DENIED and DISMISSED WITH 

PREJUDICE and the court DECLINES to issue a certificate of appealability. 

This action was (check one): 

 tried to a jury with Judge presiding, and the jury has 

rendered a verdict. 

 tried by Judge without a jury and the above decision was 

reached. 

 X decided by Judge Holly A. Brady on a Motion to Vacate under 28 U.S.C. 2255. 

DATE: 8/11/2020 ROBERT N. TRGOVICH, CLERK OF COURT 

 by s/ B. Scheumann c

 Signature of Clerk or Deputy Clerk

USDC IN/ND case 1:14-cr-00014-HAB-SLC document 571 filed 08/11/20 page 1 of 1
[Federal Register Volume 60, Number 85 (Wednesday, May 3, 1995)]
[Notices]
[Page 21820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10792]



-----------------------------------------------------------------------


FEDERAL MARITIME COMMISSION

Security for the Protection of the Public Indemnification of 
Passengers for Nonperformance of Transportation; Notice of Issuance of 
Certificate (Performance)

    Notice is hereby given that the following have been issued a 
Certificate of Financial Responsibility for Indemnification of 
Passengers for Nonperformance of Transportation pursuant to the 
provisions of Section 3, Public Law 89-777 (46 U.S.C. Sec. 817(e)) and 
the Federal Maritime Commission's implementing regulations at 46 CFR 
Part 540, as amended:

Hapag-Lloyd (America) Inc., Hapag-Lloyd Kreuzfahrten GmbH and KG MS 
``Europa'' der Breschag Bremer Schiffsvercharterungs AG & Co. KG, 
Gustav-Deetjen-Allee 2-6, Bremen D-28215, Germany.
Vessel: Europa.

    Dated: April 27, 1995.
Joseph C. Polking,
Secretary.
[FR Doc. 95-10792 Filed 5-2-95; 8:45 am]
BILLING CODE 6730-01-M